Objective-To study early
(Ann Rheum Dis 1995; 54: [45] [46] [47] [48] The small joints of the hands and feet are usually the first to become affected in the initial phase of rheumatoid arthritis (RA).1 2 Larger joints which may also be involved at an early stage include the knee, shoulder, and elbow joints. However, hip joint involvement may also occur early. We Figure 1 Schematic presentation of the patients enrolled in the early rheumatoid arthritis study.
lying supine, by internal and external rotation with the knee and hip flexed 900. Figure 1 shows the different groups of patients from the cohort investigated. A total of 113 have been followed for at least five years.
In study I the frequency of hip joint replacements performed in these patients during the period of observation was investigated. No previous hip radiograms were available, but there was no clinical evidence of pre-existing osteoarthritis of the hip.
In the second part of the investigation (study II) ultrasonography was performed in all 76 patients within the early RA cohort with disease onset January 1987 and later. There were 26 men and 50 women with a median age of 53-5 (range 29-83) years and median disease duration of 52 (23-72) months at the time ofultrasonography. Seventy eight per cent were seropositive. Sixty two patients were 
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Median values (range) and level of significance (p). NS = Not significant; ESR= erythrocyte sedimentation rate; HAQ = health assessment questionnaire. Table 1 shows the clinical and laboratory findings at the time of hip ultrasonography, grouped according to positive or negative results from ultrasonography. The patients were investigated either at the time of an annual routine radiographic examination of hands and feet, or when reporting symptoms from the hip region, which were actively elicited. Ultrasonography was performed from the anterior aspect of both hip joints using a Toshiba Sonolayer SSA-270A unit with a 7.5 MHz linear transducer PLE 705F or a 3.75 MHz sector scanner PVF 357 MT. The probe was positioned parallel to the femoral neck. The capsular height was measured from the cortex of the femoral neck to the outer layer of the capsule. The ultrasonic examination was considered pathological when the capsular height was 7 mm or greater.9 Fluid or synovial thickening that caused bulging of the capsule was also considered a pathological sign, irrespective of capsular height. The ultrasonographer was unaware of the clinical findings.
If ultrasonography was positive, radiographic examination of the hips was also performed. The radiographic changes were assessed by the method of Larsen. 10 Statistical analyses Differences between groups were assessed with the Mann-Whitney test for unpaired data. The x test was applied for discrete data. The level of significance was set at 0 05. Life table analysis was performed with the software from SPSS.
Results

STUDY I
In. the 113 patients followed for at least five years, 21 hip joint replacements were performed in 15 patients with a median age of 54-5 (range 26-66) years at the time of first arthroplasty. Table 2 summarises the clinical and laboratory findings at study entry. The median disease duration at first joint replacement was 48 (10-76) months. Figure 2 shows the probability of receiving a hip joint implant in relation to disease duration in this cohort of RA patients. The incidence was relatively constant from approximatley two years of disease duration and the prevalence reached 13% by six years of disease duration. Numbers are more uncertain above this level because of the limited number of observations. The median duration of severe hip joint symptoms before radiographic confirmation of joint destruction was 3 (1-14) months. Only one of the patients had a disease onset after January 1987. Patients who eventually received a hip joint replacement had greater disease activity when entering the study (table 2) . positive ultrasonic examination had neither signs nor symptoms of hip involvement, and were detected at routine annual radiographic examination. The remaining nine were examined because of symptoms or signs of hip involvement (four had symptoms and signs, two symptoms only, and three signs only). Signs of hip involvement mostly denoted impaired internal rotation. Symptoms and signs were mild in all cases.
Four of the 13 patients with positive ultrasonography had unequivocal radiographic changes ( Eberhardt, Fex, _Johnsson, Geborek at most (fig 2) . Demographic or genetic factors may contribute to this discrepancy. Ultrasonic evidence of hip synovitis was found in 17% of subjects. Those with synovitis had a median disease duration of three years, confirming that hip joint involvement may be a rather early event. Apart from the shorter disease duration, we found no differences regarding demographic, clinical or laboratory findings between patients with and without hip synovitis. This is in contrast to a previous ultrasonic investigation reporting longer disease duration (mean 9 4 years) and a greater frequency of rheumatoid factor negativity in patients with hip synovitis. 13 The shorter disease duration that we found in the group with hip synovitis is probably explained by our active search for hip joint involvement and subsequently early ultrasonic examination.
Interestingly, seven of the 13 patients with a positive ultrasonic examination had no symptoms at all and the remaining patients had only mild symptoms, making a treatment intervention very doubtful in a normal clinical setting, but four were found to have radiographic signs of active hip joint destruction. In addition, six patients with symptoms or signs were normal upon ultrasonic examination, illustrating the difficulties of certifying hip synovitis on clinical grounds alone. The follow up period in the patients examined by ultrasonography is at present too short to permit any conclusions of the predictive value regarding late hip joint destruction.
The mild symptoms which we actively elicited are in contrast to the severe pain in the very late stages of destruction. The patients with hip joint replacement had a median duration of severe symptoms of only three months before radiographic confirmation of severe joint destruction.
There was a striking difference between destructive hip and knee joint involvement at this stage of the disease. Only one knee joint replacement had to be performed among the 113 patients with at least five years of follow up, but detectable knee joint synovitis was common, occurring in more than 50/o of the patients. However, this apparently did not lead to the same rapid destruction of the knee joint. A contributing factor to this might be that knee joint involvement, in contrast to hip joint involvement, is easy to detect, and to treat by intra-articular glucocorticoid injections.
In conclusion, hip involvement may occur early and be rapidly progressive in RA patients. Ultrasonography is a useful tool to detect hip joint synovitis in patients with no or mild symptoms and can provide a rationale for intervention with intra-articular steroids or more aggressive pharmacotherapy at an early stage.
